NFE2L2 and familial dilated cardiomyopathy: Importantly, FGF1ΔHBS treatment greatly diminished these abnormalities, which may leverage the rescued expression of Nrf2 and its downstream targets in the hearts since Nrf2 is an important transcription factor in detoxification signaling of oxidative stress in DCM.36